Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome
- PMID: 10323476
- PMCID: PMC6807861
- DOI: 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C
Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome
Abstract
Glucose transport into the brain is mediated by a facilitative glucose-transporter protein, GLUT-1. A GLUT-1 defect results in the Glucose-Transporter-Protein Syndrome (GTPS), characterized by infantile epilepsy, developmental delay, and acquired microcephaly. The diagnosis is currently based on clinical features, low to normal lactate levels and low glucose levels (hypoglycorrhachia) in the cerebrospinal fluid, and the demonstration of impaired GLUT-1 function in erythrocytes as described here. Blood samples were collected in sodium-heparin or citrate-phosphate-dextrose solution and uptake of 14C-labeled 3-O-Methyl-D-glucose (3OMG into erythrocytes (0.5 mmol/L 3OMG; 1 microCi/mL) was measured at 4C and pH 7.4. Three-OMG influx was terminated at 5-second intervals, washed cells were lysed, and uptake was quantitated by liquid scintillation counting. Patients' uptake (n = 22) was 44 +/- 8% of controls (100 +/- 22%, n = 70). Statistical analyses showed an uptake cut-off point at 60% uptake, a sensitivity of 86% (95%-confidence interval 78 to 94%), and a specificity of 97% (95%-confidence interval 93 to 100%). Gender, age, and ketosis did not influence 3OMG uptake. This assay provides a reproducible and accurate laboratory test for diagnosing the GTPS.
Similar articles
-
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.Ann Neurol. 2005 Jan;57(1):111-8. doi: 10.1002/ana.20331. Ann Neurol. 2005. PMID: 15622525 Clinical Trial.
-
Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome.Neurochem Res. 1999 Apr;24(4):587-94. doi: 10.1023/a:1022544131826. Neurochem Res. 1999. PMID: 10227690
-
T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake.Brain Dev. 2011 Apr;33(4):316-20. doi: 10.1016/j.braindev.2010.06.012. Epub 2010 Jul 13. Brain Dev. 2011. PMID: 20630673
-
Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review.Eur J Pediatr. 2002 Jun;161(6):295-304. doi: 10.1007/s00431-002-0939-3. Epub 2002 Apr 16. Eur J Pediatr. 2002. PMID: 12029447 Review.
-
[Glucose transporter-1 deficiency syndrome can cause various clinical symptoms].Ugeskr Laeger. 2013 Dec 9;175(50A):V04130248. Ugeskr Laeger. 2013. PMID: 25353328 Review. Danish.
Cited by
-
Establishment of a flow cytometry screening method for patients with glucose transporter 1 deficiency syndrome.Mol Genet Metab Rep. 2023 Jan 2;34:100954. doi: 10.1016/j.ymgmr.2022.100954. eCollection 2023 Mar. Mol Genet Metab Rep. 2023. PMID: 36618999 Free PMC article.
-
Introduction of a ketogenic diet in young infants.J Inherit Metab Dis. 2002 Oct;25(6):449-60. doi: 10.1023/a:1021238900470. J Inherit Metab Dis. 2002. PMID: 12555938
-
Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants.J Biol Chem. 2008 Jun 13;283(24):16732-42. doi: 10.1074/jbc.M801403200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387950 Free PMC article.
-
Red blood cells as glucose carriers to the human brain: Modulation of cerebral activity by erythrocyte exchange transfusion in Glut1 deficiency (G1D).J Cereb Blood Flow Metab. 2023 Mar;43(3):357-368. doi: 10.1177/0271678X221146121. Epub 2022 Dec 15. J Cereb Blood Flow Metab. 2023. PMID: 36523131 Free PMC article.
-
A fuzzy model of glucose regulation.J Med Syst. 2006 Jun;30(3):187-203. doi: 10.1007/s10916-005-7983-2. J Med Syst. 2006. PMID: 16848132
References
-
- Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science 1985;28:941–945. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous